GlassScriptPhysician profile
Bianca Robinson
NPI 1760068191
$2,460.48
in general payments reported to CMS, 2019-2025
16 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 89% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $28.39 · 2024: $1,287 · 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,465 · Travel and Lodging: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,465.03 |
| Travel and Lodging | $995.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,304.44 | 2024-2025 | Minimed 780g, Intellis Adaptivestim, Inceptiv |
| Sanofi-Aventis U.S. LLC | $226.87 | 2023-2025 | |
| Lilly USA, LLC | $213.18 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $180.31 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $165.26 | 2024-2025 | Veozah |
| Radius Health, INC. | $79.92 | 2024-2025 | Tymlos |
| Dexcom, INC. | $66.59 | 2024-2025 | Dexcom G6 Transmitter |
| Cequr Corporation | $42.50 | 2024 | Cequr Simplicity |
| Madrigal Pharmaceuticals | $30.62 | 2025 | Rezdiffra |
| Insulet Corporation | $28.06 | 2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $27.88 | 2024 | Strensiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.26 | 2025 | Jardiance |
| Ionis Pharmaceuticals, INC. | $21.83 | 2025 | Tryngolza |
| Corcept Therapeutics | $18.87 | 2024 | Korlym |
| Sequel Med Tech, LLC | $18.21 | 2025 | Twiist |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $13.68 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.